Stephens Inc. AR Grows Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Stephens Inc. AR increased its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 33.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,836 shares of the company’s stock after buying an additional 1,477 shares during the period. Stephens Inc. AR’s holdings in Ryan Specialty were worth $374,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in RYAN. Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Ryan Specialty by 0.4% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,235,114 shares of the company’s stock valued at $79,245,000 after purchasing an additional 4,907 shares in the last quarter. State of Alaska Department of Revenue lifted its holdings in shares of Ryan Specialty by 1.6% in the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company’s stock valued at $778,000 after purchasing an additional 190 shares in the last quarter. Retirement Systems of Alabama lifted its holdings in shares of Ryan Specialty by 4.1% in the fourth quarter. Retirement Systems of Alabama now owns 129,368 shares of the company’s stock valued at $8,300,000 after purchasing an additional 5,099 shares in the last quarter. DAVENPORT & Co LLC lifted its holdings in shares of Ryan Specialty by 9.9% in the fourth quarter. DAVENPORT & Co LLC now owns 4,144 shares of the company’s stock valued at $266,000 after purchasing an additional 374 shares in the last quarter. Finally, R Squared Ltd purchased a new stake in shares of Ryan Specialty in the fourth quarter valued at about $92,000. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Insiders Place Their Bets

In other news, Director David P. Bolger sold 7,055 shares of the firm’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the transaction, the director now owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. This trade represents a 8.28 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Nicholas Dominic Cortezi sold 31,409 shares of the firm’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the completion of the transaction, the director now directly owns 2,697 shares in the company, valued at approximately $177,031.08. This represents a 92.09 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 323,506 shares of company stock valued at $21,407,851 over the last quarter. Company insiders own 11.10% of the company’s stock.

Ryan Specialty Stock Performance

NYSE:RYAN opened at $68.75 on Friday. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The company has a market cap of $18.00 billion, a P/E ratio of 89.29, a P/E/G ratio of 1.19 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a fifty-two week low of $44.84 and a fifty-two week high of $75.97. The firm’s 50 day moving average is $65.53 and its two-hundred day moving average is $67.14.

Analysts Set New Price Targets

Several brokerages have issued reports on RYAN. Keefe, Bruyette & Woods reduced their price target on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a report on Friday, January 10th. Barclays upped their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Morgan Stanley assumed coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They set an “overweight” rating and a $90.00 price objective on the stock. Finally, Wells Fargo & Company reduced their price objective on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 14th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $74.40.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.